Antonio Portarapillo

8PUBLICATIONS
50CO-AUTHORS
AllergyEpidemiological methodsReaction kinetics and dynamicsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Aug 02, 2025
Jarisch-Herxheimer-Like Reaction After Griseofulvin Oral Intake for Tinea Infection Treatment.

Francesca Gaudiello, Antonia Salsano, Lucia Gallo

|Jun 04, 2024
The role of teledermatology for the long-term management of stable psoriasis treated with biologics: a survey-based study.

Antonio Portarapillo, Valeria Esposito, Matteo Megna

|Jun 04, 2024
Risk Factors for Psoriasis Flares: A Narrative Review.

Luca Potestio, Giuseppe Lauletta, Nello Tommasino

|Mar 13, 2024
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report.

Fabrizio Martora, Teresa Battista, Luca Potestio

Pageof 2

Frequent Collaborators

4 joint publications

Fabrizio Martora

4 joint publications

Luca Potestio

3 joint publications

Angelo Ruggiero

3 joint publications

Maddalena Napolitano